血清UA水平与脑梗死患者颅内外动脉粥样硬化性狭窄的关系

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (628 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the relationship between serum uric acid (UA) level and intracranial/extracranial atherosclerotic stenosis (ICAS/EAS) in patients with cerebral infarction. Methods A total of 216 patients with cerebral infarction who were followed up in Guizhou Orthopedic Hospital from January 2019 to January 2020 were selected as the research objects. According to the presence or absence of ICAS/EAS, the patients were divided into the stenosis group (150 cases) and the control group (66 cases). The differences of serum UA level and general clinical data between the two groups were compared. The expression of serum UA levels in patients with different severity of ICAS/EAS were analyzed, and the relationship between UA level and ICAS/EAS severity were analyzed, the influencing factors of ICAS/EAS in patients with cerebral infarction was explored. Results The UA level, age, body mass index (BMI), total cholesterol (TC), low density lipoprotein (LDL) and the proportion of hypertension in the stenosis group were higher than those of the control group, while the serum high density lipoprotein (HDL) level was lower than that of the control group (all P ＜ 0.05). The UA levels of severe, moderate and mild group were higher than that of the control group, the severe, moderate group were higher than that of the mild group, and the severe group was higher than that of the moderate group (all P ＜ 0.05). Spearman correlation analysis showed that serum UA level was positively correlated with ICAS/EAS severity (rs = 0.634, P ＜ 0.001). Logistic regression analysis showed that UA (OR = 3.748), age (OR = 2.895), hypertension (OR = 3.024), TC (OR = 2.668), and LDL (OR = 2.349) were all risk factors for ICAS/EAS in patients with cerebral infarction (all P ＜ 0.05). Conclusion Serum UA level can better reflect the severity of ICAS/EAS in patients with cerebral infarction, and it is an independent risk factor of ICAS/EAS.

Key words： Cerebral infarction Intracranial / external atherosclerotic stenosis Uric acid Risk factor

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YUAN Baowen1 LI Chouzhong2 CHEN Yufeng3 WEI Ling3

Cite this article:

YUAN Baowen1 LI Chouzhong2 CHEN Yufeng3 WEI Ling3. Relationship between serum UA level and intracranial / extracranial atherosclerotic stenosis in patients with cerebral infarction[J]. 中国医药导报, 2021, 18(5): 61-64.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2021/V18/I5/61

[1] 穆静，穆林，张力新.高同型半胱氨酸血症与脑梗死病人主动脉硬化的相关性分析[J].中西医结合心脑血管病杂志，2018，16（5）：644-646.
[2] 张雪，李华，邓馨，等.尿酸与卒中的相关性研究进展[J].武警医学，2016，27（7）：739-742.
[3] 牛爽，康蓓，郭荷娜.脑梗死合并糖尿病患者颅内外动脉粥样硬化性狭窄的特征研究[J].临床医学研究与实践，2020，5（8）：130-131，134.
[4] 刘真成，边云飞，李嘉伟，等.血清尿酸与心血管疾病相关性的研究进展[J].中国医药导报，2019，16（29）：45-48.
[5] 马莉莉，蒋麟，王婷婷，等.高基础水平血尿酸与动脉硬化的相关性及其预测作用[J].临床和实验医学杂志，2020， 19（7）：748-751.
[6] 刘鸣，贺茂林.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志，2015，48（4）：246-257.
[7] 陈伟红，刘扬，李睿，等.症状性颅内动脉粥样硬化性狭窄的研究进展[J].卒中与神经疾病，2018，25（6）：739-742.
[8] 王磊，李文霞.颅内动脉粥样硬化性狭窄程度与缺血性脑卒中复发相关性研究[J].中国医药科学，2020，10（6）：235-238.
[9] 杨灵灵，尚进林.症状性颅内动脉粥样硬化性狭窄的研究进展[J].中国实用神经疾病杂志，2018，21（21）：2431-2436.
[10] 施佳成，黄倩，沈艳明，等.不同血清尿酸水平与心血管疾病危险因素的相关性研究[J].江西医药，2020，55（8）：984-988.
[11] 张亮，赵连山.高尿酸血症与缺血性脑卒中复发及动脉粥样硬化性颅内动脉狭窄的相关性[J].血栓与止血学，2017，23（1）：55-57.
[12] Huang G，Qin J，Deng X，et al. Prognostic value of serum uric acid in patients with acute heart failure：A meta-analysis [J]. Medicine：Baltimore，2019，98（8）：e14525.
[13] 柴转英.脑梗死患者血清Hcy，UA与头颈部血管动脉粥样硬化及狭窄的相关性[J].临床医学，2015，1（4）：21-23.
[14] 汤群英，于建刚，徐红.血清尿酸水平与老年脑梗死患者颅内外动脉粥样硬化性狭窄的关系研究[J].实用心脑肺血管病杂志，2020，28（4）：34-37.
[15] Lai YJ，Hsu CY. Is serum uric acid a predictive factor for stroke in men with hypertriglyceridemia？[J]. Bratisl Lek Listy，2019，120（4）：316-319.
[16] 孙尧，徐艳丽，程燕，等.绝经后女性冠心病患者与血浆脂蛋白（a）、胱抑素C、尿酸的关系[J].中国医药导报，2012，9（12）：93-94，97.
[17] Pak S，Yatsynovich Y，Valencia D，et al. Serum Uric Acid and Atrial Fibrillation：Meta-analysis [J]. Crit Pathw Cardiol，2018，20（3）：560-567.
[18] 周丽，任娟，秦欢，等.血清hs-CRP、Cys C、UA水平与H型高血压合并脑梗死患者动脉粥样硬化程度的关系研究[J].国际检验医学杂志，2020，41（12）：1465-1467， 1472.
[19] 詹俊琳，王泽彬，梁剑波，等.尿酸和C反应蛋白与腹膜透析患者颈动脉硬化的关系[J].广东医学，2019，40（2）：285-288.
[20] 李佳，徐秋焕，陈涛，等.高尿酸血症对颅内动脉粥样硬化的影响[J].心血管康复医学杂志，2019，28（2）：165-169.
[21] 韦广明.脑梗死患者血清Hcy、UA与头颈部血管动脉粥样硬化及狭窄的相关性[J].中西医结合心血管病电子杂志，2020，8（13）：25-26.
[22] 朱振国，黄艳君，陈艳艳，等.脑梗死伴颅内动脉粥样硬化性狭窄的影响因素分析[J].浙江医学，2016，38（13）：1066-1068，1085.
[23] 陈静，郝玉曼，秦新月.颅内动脉粥样硬化性狭窄的研究进展[J].现代临床医学，2016，42（1）：18-21，24.
[24] 李冬华，王海鹏，刘洁，等.进展性缺血性卒中预测指标的临床研究[J].中国慢性病预防与控制，2016，24（12）：894-898，903.
[25] 吴立丰，倪琴，陈婷，等.颈动脉硬化病人颈总动脉硬化度、颈动脉IMT及其与预后的关系[J].中西医结合心脑血管病杂志，2020，18（7）：1152-1154.